2017 Q3 Form 10-Q Financial Statement

#000143774917018197 Filed on November 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $31.47M $27.87M
YoY Change 12.92% -8.97%
Cost Of Revenue $17.91M $15.49M
YoY Change 15.6% -12.29%
Gross Profit $6.486M $6.402M
YoY Change 1.31% 1.41%
Gross Profit Margin 20.61% 22.97%
Selling, General & Admin $3.360M $3.070M
YoY Change 9.45% 3.02%
% of Gross Profit 51.8% 47.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $367.0K $349.0K
YoY Change 5.16% 4.8%
% of Gross Profit 5.66% 5.45%
Operating Expenses $3.730M $3.410M
YoY Change 9.38% 3.02%
Operating Profit $8.734M $8.031M
YoY Change 8.75% -4.69%
Interest Expense -$3.630M -$3.630M
YoY Change 0.0% -0.82%
% of Operating Profit -41.56% -45.2%
Other Income/Expense, Net $21.00K $21.00K
YoY Change 0.0% -16.0%
Pretax Income $5.127M $4.425M
YoY Change 15.86% -7.6%
Income Tax $2.007M $1.918M
% Of Pretax Income 39.15% 43.34%
Net Earnings $3.120M $2.507M
YoY Change 24.45% -11.94%
Net Earnings / Revenue 9.91% 9.0%
Basic Earnings Per Share $0.75 $0.60
Diluted Earnings Per Share $0.74 $0.60
COMMON SHARES
Basic Shares Outstanding 4.179M 4.172M
Diluted Shares Outstanding 4.212M 4.207M

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.70M $55.10M
YoY Change 11.98% -7.24%
Cash & Equivalents $61.68M $55.13M
Short-Term Investments
Other Short-Term Assets $356.0K $348.0K
YoY Change 2.3% 21.68%
Inventory $604.0K $507.0K
Prepaid Expenses
Receivables $10.10M $7.700M
Other Receivables $1.400M $1.400M
Total Short-Term Assets $74.28M $65.18M
YoY Change 13.96% -8.5%
LONG-TERM ASSETS
Property, Plant & Equipment $8.466M $8.923M
YoY Change -5.12% 1.2%
Goodwill $95.00K $95.00K
YoY Change 0.0% 0.0%
Intangibles $1.353M $1.353M
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets $293.0K $94.00K
YoY Change 211.7% -72.59%
Total Long-Term Assets $10.21M $10.47M
YoY Change -2.47% -1.35%
TOTAL ASSETS
Total Short-Term Assets $74.28M $65.18M
Total Long-Term Assets $10.21M $10.47M
Total Assets $84.49M $75.65M
YoY Change 11.68% -7.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.128M $4.167M
YoY Change 23.06% -9.33%
Accrued Expenses $5.184M $5.991M
YoY Change -13.47% 7.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.51M $10.26M
YoY Change 2.47% -2.02%
LONG-TERM LIABILITIES
Long-Term Debt $132.1M $130.9M
YoY Change 0.91% 0.93%
Other Long-Term Liabilities $1.455M $1.639M
YoY Change -11.23% -29.48%
Total Long-Term Liabilities $133.5M $132.5M
YoY Change 0.76% 0.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.51M $10.26M
Total Long-Term Liabilities $133.5M $132.5M
Total Liabilities $144.9M $143.5M
YoY Change 0.96% 0.05%
SHAREHOLDERS EQUITY
Retained Earnings -$43.82M -$51.29M
YoY Change -14.56% -12.0%
Common Stock $60.72M $60.73M
YoY Change -0.02% 0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost) $77.30M $77.30M
YoY Change 0.0% 20.76%
Treasury Stock Shares $5.127M $5.127M
Shareholders Equity -$60.41M -$67.87M
YoY Change
Total Liabilities & Shareholders Equity $84.49M $75.65M
YoY Change 11.68% -7.58%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $3.120M $2.507M
YoY Change 24.45% -11.94%
Depreciation, Depletion And Amortization $367.0K $349.0K
YoY Change 5.16% 4.8%
Cash From Operating Activities $1.010M $2.610M
YoY Change -61.3% 38.1%
INVESTING ACTIVITIES
Capital Expenditures -$160.0K -$330.0K
YoY Change -51.52% 312.5%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$160.0K -$330.0K
YoY Change -51.52% -104.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 1.010M 2.610M
Cash From Investing Activities -160.0K -330.0K
Cash From Financing Activities 0.000 0.000
Net Change In Cash 850.0K 2.280M
YoY Change -62.72% -70.88%
FREE CASH FLOW
Cash From Operating Activities $1.010M $2.610M
Capital Expenditures -$160.0K -$330.0K
Free Cash Flow $1.170M $2.940M
YoY Change -60.2% 49.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
nath Accounts Receivable Payment Terms
AccountsReceivablePaymentTerms
P30D
CY2017Q3 nath Accrued Construction Costs Current
AccruedConstructionCostsCurrent
106000
CY2017Q1 nath Accrued Construction Costs Current
AccruedConstructionCostsCurrent
160000
CY2017 nath Advertising Fund Contributions From Franchises And Other Third Parties
AdvertisingFundContributionsFromFranchisesAndOtherThirdParties
2572000
CY2017Q3 nath Dilutive Securities Effect On Earnings Per Share
DilutiveSecuritiesEffectOnEarningsPerShare
-0.01
CY2016Q3 nath Dilutive Securities Effect On Earnings Per Share
DilutiveSecuritiesEffectOnEarningsPerShare
nath Dilutive Securities Effect On Earnings Per Share
DilutiveSecuritiesEffectOnEarningsPerShare
-0.02
nath Dilutive Securities Effect On Earnings Per Share
DilutiveSecuritiesEffectOnEarningsPerShare
-0.01
CY2017Q3 nath Dividends Payable Noncurrent
DividendsPayableNoncurrent
CY2017Q1 nath Dividends Payable Noncurrent
DividendsPayableNoncurrent
125000
CY2013Q2 nath Minimum Percentage Of Common Stock Acquired By A Person Or Group Which Triggers Exercise Of New Rights
MinimumPercentageOfCommonStockAcquiredByAPersonOrGroupWhichTriggersExerciseOfNewRights
0.15
CY2013Q2 nath New Right Purchase Price
NewRightPurchasePrice
100
CY2017Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
11527000
CY2017Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
8948000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5128000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4809000
CY2017Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
12026000
CY2017Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
9405000
CY2017Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
718000
CY2017Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
143000
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5184000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5865000
CY2017Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1271000
CY2017Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1050000
CY2017Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
70000
CY2017Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
109000
CY2017Q3 us-gaap Accrued Rent Current
AccruedRentCurrent
233000
CY2017Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
215000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8204000
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7522000
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
60624000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
60582000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
157000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
199000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
173000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
199000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
346000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
457000
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
471000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
499000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
15000
CY2017 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
67000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
599000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
611000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2017Q3 us-gaap Assets
Assets
84488000
CY2017Q1 us-gaap Assets
Assets
78125000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
74281000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
67535000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56915000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50228000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61677000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55125000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4762000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4897000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10188600
CY2017Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6271192
CY2015Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
25
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9311922
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9303870
us-gaap Cost Of Goods Sold
CostOfGoodsSold
35566000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
30947000
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
22872000
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
19982000
us-gaap Costs And Expenses
CostsAndExpenses
45340000
us-gaap Costs And Expenses
CostsAndExpenses
40574000
CY2017Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
135000000
CY2017Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
135000000
CY2017Q3 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
110000
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4184549
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4176497
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
93000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
93000
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
18041000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
15489000
CY2017Q1 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
67000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
40000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
27000
CY2017Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
729000
CY2017Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
786000
CY2017Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
854000
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
814000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
735000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
696000
CY2017Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
367000
CY2016Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
349000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">NOTE <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">C &#x2013; NEW ACCOUNTING PRONOUNCEMENTS <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">NOT</div> YET ADOPTED</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the FASB issued a new accounting standard that attempts to establish a uniform basis for recording <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">revenue to virtually all industries&#x2019; financial statements, under U.S. GAAP as further amended during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The FASB issued certain updates to the standard, including clarifying reporting revenue between Principle versus Agent and clarification in determining performance obligations and licenses guidance. The revenue standard&#x2019;s core principle is built on the contract between a vendor and a customer for the provision of goods and services. It attempts to depict the exchange of rights and obligations between the parties in the pattern of revenue recognition based on the consideration to which the vendor is entitled.<div style="display: inline; font-weight: bold;"> </div>In order to accomplish this objective, companies must evaluate the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> basic steps: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. </div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> basic transition methods that are available <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; full retrospective, or modified retrospective transition methods. Early adoption is prohibited. Public companies were originally expected to apply the new standard for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>including interim periods therein, which for Nathan&#x2019;s would have been its <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 27, 2017. </div>On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 9, 2015, </div>the FASB agreed to delay the standard&#x2019;s effective date to annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017 </div>which will now be our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2018) </div>of our fiscal year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019. </div></div></div> <div style=" font-family: Times\ New\ Roman, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</div> <div style=" font-family: Times\ New\ Roman, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company has assigned internal resources to evaluate and implement the new standard, and will continue to provide updates during fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp; The Company is continuing its evaluation of the impact of the new standard, but currently does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that the standard will impact its recognition of revenue for its Company-operated restaurants or its recognition of royalties from its franchised restaurants or retail licenses, which are based on a percentage of sales.&nbsp; The Company is still assessing the impact of the new standard on revenues from its Branded Product Program as well as decisions reached by the FASB Transition Resource Group in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2016 </div>on the treatment of minimum guarantees in licensing arrangements, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>affect the timing of the Company&#x2019;s recognition of royalty revenues. Currently, franchise and international development fees are recognized when the Company has performed substantially all initial services required by the agreements, which is generally when the franchisee begins operations.&nbsp; Under the new guidance, these fees <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be recognized over the term of the agreements. The Company also expects that the adoption of this new guidance <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>change the reporting of contributions to the advertising fund from franchisees and other <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> parties and the related advertising fund expenditures, which are currently reported on a net basis in the Consolidated Statements of Earnings and Consolidated Balance Sheets.&nbsp; The Company expects the new guidance will require these advertising fund contributions and expenditures to be reported on a gross basis in the Consolidated Statement of Earnings.&nbsp; For the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 26, 2017, </div>advertising fund contributions from franchisees and other <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> parties were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,572,000,</div> and therefore we expect this change <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>impact our total revenues and expenses.&nbsp; The Company plans to adopt this standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 26, 2018, </div>using the modified retrospective method.&nbsp; </div></div> <div style=" font-family: Times\ New\ Roman, Times, serif; font-size: 10pt; margin: 0pt;"></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued a new accounting standard on leases. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">The new standard, among other changes, will require lessees to recognize a right-of-use asset and a lease liability on the balance sheet for all leases. The lease liability will be measured at the present value of the lease payments over the lease term. The right-of-use asset will be measured at the lease liability amount, adjusted for lease prepayments, lease incentives received and the lessee&#x2019;s initial direct costs (e.g. commissions). The new standard is effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>including interim reporting periods within those annual reporting periods. This standard is required to take effect in Nathan&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2019) </div>of our fiscal year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 29, 2020. </div>The adoption will require a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest period presented. The Company is currently evaluating the standard to determine the impact of the adoption on its consolidated financial statements but expects that the standard will result in a significant increase to its other assets and other liabilities.</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>the FASB issued an update to the accounting guidance to simplify the testing for goodwill impairment. The update removes the requirement to determine the implied fair value of goodwill to measure the amount of impairment loss, if any, under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> step of the current goodwill impairment test. A company will perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. A goodwill impairment charge will be recognized for the amount by which the reporting unit<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s carrying amount exceeds its fair value, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to exceed the carrying amount of the goodwill. The guidance is effective prospectively for public business entities for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2019. </div>This standard is required to take effect in Nathan&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2020) </div>of our fiscal year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 28, 2021. </div>Nathan&#x2019;s does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the adoption of this new guidance to have a material impact on its results of operations or financial position.</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that any other recently issued, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet effective accounting standards, when adopted, will have a material effect on the accompanying financial statements.</div></div>
CY2017Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
5
CY2017Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
125000
CY2017Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
125000
CY2015Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1000000
CY2015Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2015-03-20
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.45
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.44
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.394
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.369
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.019
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.064
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1771000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2708000
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
300000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P300D
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
194000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
621000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-194000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-621000
CY2017Q3 us-gaap Franchise Revenue
FranchiseRevenue
1315000
CY2016Q3 us-gaap Franchise Revenue
FranchiseRevenue
1334000
us-gaap Franchise Revenue
FranchiseRevenue
2487000
us-gaap Franchise Revenue
FranchiseRevenue
2664000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3359000
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3066000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7030000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6915000
CY2017Q3 us-gaap Goodwill
Goodwill
95000
CY2017Q1 us-gaap Goodwill
Goodwill
95000
CY2017Q1 us-gaap Guaranty Liabilities
GuarantyLiabilities
204000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5127000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4425000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9970000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9595000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2007000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1918000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3928000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3538000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3400000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2099000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
2636000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
403000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-431000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1401000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
102000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-36000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-180000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-5000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-15000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-100000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-67000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-620000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-894000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
33000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
35000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
35000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
30000
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1353000
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1353000
CY2017Q3 us-gaap Interest Expense Other
InterestExpenseOther
3663000
CY2016Q3 us-gaap Interest Expense Other
InterestExpenseOther
3663000
us-gaap Interest Expense Other
InterestExpenseOther
7326000
us-gaap Interest Expense Other
InterestExpenseOther
7339000
us-gaap Interest Paid
InterestPaid
6750000
us-gaap Interest Paid
InterestPaid
6750000
CY2017Q3 us-gaap Interest Payable Current
InterestPayableCurrent
441000
CY2017Q1 us-gaap Interest Payable Current
InterestPayableCurrent
463000
CY2017Q3 us-gaap Inventory Net
InventoryNet
604000
CY2017Q1 us-gaap Inventory Net
InventoryNet
579000
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
35000
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
36000
us-gaap Investment Income Interest
InvestmentIncomeInterest
70000
us-gaap Investment Income Interest
InvestmentIncomeInterest
36000
CY2017Q3 us-gaap Liabilities
Liabilities
144895000
CY2017Q1 us-gaap Liabilities
Liabilities
144616000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84488000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78125000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10512000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10772000
CY2017Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
404000
CY2017Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
366000
CY2017Q3 us-gaap Licenses Revenue
LicensesRevenue
5764000
CY2016Q3 us-gaap Licenses Revenue
LicensesRevenue
4788000
us-gaap Licenses Revenue
LicensesRevenue
13165000
us-gaap Licenses Revenue
LicensesRevenue
11612000
CY2017Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
142088000
CY2017Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
132074000
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
131475000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-282000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2058000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-357000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-606000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5401000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7561000
us-gaap Net Income Loss
NetIncomeLoss
6042000
us-gaap Net Income Loss
NetIncomeLoss
6057000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
3120000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
2507000
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3120000
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2507000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6042000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6057000
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3120000
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2507000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6042000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6057000
CY2017Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1105000
CY2016Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1078000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2009000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2016000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8734000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8031000
us-gaap Operating Income Loss
OperatingIncomeLoss
17184000
us-gaap Operating Income Loss
OperatingIncomeLoss
16855000
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
249000
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
169000
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
356000
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
774000
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
293000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
298000
CY2017Q3 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
212000
CY2017Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
211000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1455000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1555000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21000
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
42000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1272000
CY2015Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
115100000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
875000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
125000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
125000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
157000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
705000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
357000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
606000
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
473000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1093000
CY2017Q3 us-gaap Prepaid Insurance
PrepaidInsurance
117000
CY2017Q1 us-gaap Prepaid Insurance
PrepaidInsurance
319000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
44000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8466000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8844000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
57000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
53000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43821000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49863000
CY2017Q3 us-gaap Revenues
Revenues
31606000
CY2016Q3 us-gaap Revenues
Revenues
28013000
us-gaap Revenues
Revenues
62524000
us-gaap Revenues
Revenues
57429000
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
24527000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
21891000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
46872000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
43153000
us-gaap Share Based Compensation
ShareBasedCompensation
199000
us-gaap Share Based Compensation
ShareBasedCompensation
346000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
10000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
49.80
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
49.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
5000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
49.80
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
35.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
379000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1899000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2306000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75745
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
64384
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.58
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.58
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
45444
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
35.58
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2015Q1 us-gaap Share Price
SharePrice
73.56
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1628000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y313D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y131D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y313D
CY2017Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
5000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11361
CY2017Q3 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
260258
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-60407000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-66491000
CY2017Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
16896000
CY2017Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
10812000
CY2017Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
5127373
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
5127373
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5127373
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2017Q3 us-gaap Treasury Stock Value
TreasuryStockValue
77303000
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
77303000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
77303000
CY2017Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
2926000
CY2017Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3525000
CY2017Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
208000
CY2017Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
201000
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4212000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4207000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4213000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4199000
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4179000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4172000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4178000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4169000

Files In Submission

Name View Source Status
0001437749-17-018197-index-headers.html Edgar Link pending
0001437749-17-018197-index.html Edgar Link pending
0001437749-17-018197.txt Edgar Link pending
0001437749-17-018197-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
a2.jpg Edgar Link pending
a3.jpg Edgar Link pending
a4.jpg Edgar Link pending
a5.jpg Edgar Link pending
a6.jpg Edgar Link pending
ex_97489.htm Edgar Link pending
ex_97490.htm Edgar Link pending
ex_97491.htm Edgar Link pending
ex_97492.htm Edgar Link pending
ex_97755.htm Edgar Link pending
ex_97756.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nath-20170924.xml Edgar Link completed
nath-20170924.xsd Edgar Link pending
nath-20170924_cal.xml Edgar Link unprocessable
nath-20170924_def.xml Edgar Link unprocessable
nath-20170924_lab.xml Edgar Link unprocessable
nath-20170924_pre.xml Edgar Link unprocessable
nath20170924_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending